Citigroup issued a rating report on Illumina, while MarketBeat aggregated the stock rating data.
4 reports, 1 independent
Updated Oct 7
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup issued a rating report on Illumina, while MarketBeat aggregated the stock rating data.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink and RBC boost Illumina's price target.1 source
Citigroup issued a rating report on Illumina, and MarketBeat aggregated the stock rating data.1 source
Keep exploring
The entities involved
-
Illumina
American company that develops systems for the analysis of genetic variation
-
Citigroup
American investment bank and financial services corporation
-
MarketBeat
American personal finance blog
Related events
- Citigroup reiterated a market outperform rating for Alphabet Inc.
- Citigroup reiterated a market perform rating, Bank of America restated an underperform rating, and Raymond James Financial started coverage for Omega Healthcare Investors, Inc.
- Citigroup raised its rating on Innate Pharma stock, which trades on the Nasdaq exchange. Leerink Partners also upgraded the rating. MarketBeat aggregates the rating data.
- Citigroup lifted its price target and gave a buy rating for Timken Company, with MarketBeat providing consensus data.
- Citigroup reissued a market outperform rating for Applied Digital Corporation on October 15, 2026.